TESTING CELL-FREE FETAL DNA EMERGES AS TRISOMY SCREEN OF CHOICE Informing women about selective use of test beyond fetal sex and common aneuploidies is encouraged

被引：0
|
作者：
Levenson, Deborah
机构：
来源：
AMERICAN JOURNAL OF MEDICAL GENETICS PART A | 2016年 / 170卷 / 11期
关键词：
D O I：
10.1002/ajmg.a.38006
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：2764 / 2765
页数：2
相关论文
共 50 条
  • [31] Impact of Cell-Free Fetal DNA Screening on Patients' Choice of Invasive Procedures after a Positive California Prenatal Screen Result
    Shah, Forum T.
    French, Kathryn Steinhaus
    Osann, Kathryn E.
    Bocian, Maureen
    Jones, Marilyn C.
    Korty, Lauren
    JOURNAL OF CLINICAL MEDICINE, 2014, 3 (03): : 849 - 864
  • [32] Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women
    Oxenford, Kerry
    Silcock, Caroline
    Hill, Melissa
    Chitty, Lyn
    PRENATAL DIAGNOSIS, 2013, 33 (07) : 688 - 694
  • [33] A Systematic Review and Meta-analysis of Cell-Free DNA Testing for Detection of Fetal Sex Chromosome Aneuploidy Comment
    Shear, Matthew A.
    Swanson, Kate
    Garg, Ria
    Jelin, Angie C.
    Boscardin, John
    Norton, Mary E.
    Sparks, Teresa N.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2023, 78 (08) : 464 - 466
  • [34] Should cell-free fetal DNA be included in first trimester screening (FTS) for common trisomy? A possible scenario on 6697 women screened over 10years
    Rosignoli, Lucia
    Tonni, Gabriele
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2016, 22 (06) : 899 - 906
  • [35] Enoxaparin sodiumFalse-negative cell-free DNA test result for trisomy 21 due to a low fetal DNA fraction in maternal plasma: case report
    Reactions Weekly, 2018, 1727 (1) : 124 - 124
  • [36] Is cell-free fetal DNA testing a safe option for women in a high-risk population after combined first-trimester testing?
    Dap, Matthieu
    Caffin, Lucie
    Perdriolle-Galet, Estelle
    Bonnet, Celine
    Morel, Olivier
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2022, 51 (04)
  • [37] First-Trimester Contingent Screening for Trisomy 21 by Fetal Nuchal Translucency and Maternal Serum Biomarkers and Maternal Blood Cell-Free DNA Testing
    Younesi, Sarang
    Savad, Shahram
    Ghafouri-Fard, Soudeh
    Taheri-Amin, Mohammad Mahdi
    Saadati, Pourandokht
    Jamali, Soudabeh
    Balvayeh, Payam
    Delshad, Saeed
    Navidpour, Fariba
    Adiban, Farzaneh
    Amidi, Saloomeh
    Modarressi, Mohammad Hossein
    JOURNAL OF FETAL MEDICINE, 2018, 5 (03) : 139 - 143
  • [38] Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis
    Caroline F Wright
    Yinghui Wei
    Julian PT Higgins
    Gurdeep S Sagoo
    BMC Research Notes, 5 (1)
  • [39] Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology: a prospective interventional study
    Costa, Jean-Marc
    Letourneau, Alexandra
    Favre, Romain
    Bidat, Laurent
    Belaisch-Allart, Joelle
    Jouannic, Jean-Marie
    Quarello, Edwin
    Senat, Marie-Victoire
    Broussin, Bernard
    Tsatsaris, Vassilis
    Demain, Adele
    Kleinfinger, Pascale
    Lohmann, Laurence
    Agostini, Helene
    Bouyer, Jean
    Benachi, Alexandra
    GENETICS IN MEDICINE, 2018, 20 (11) : 1346 - 1353
  • [40] Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA
    Mckanna, T.
    Ryan, A.
    Krinshpun, S.
    Kareht, S.
    Marchand, K.
    Grabarits, C.
    Ali, M.
    Mcelheny, A.
    Gardiner, K.
    Lechien, K.
    Hsu, M.
    Saltzman, D.
    Stosic, M.
    Martin, K.
    Benn, P.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2019, 53 (01) : 73 - 79
12345